Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BANK OF AMERICA CORP /DE/BAC · Entity 2801 | Director | April 29, 2009 | May 01, 2009 |
| CVS HEALTH CorpCVS · Entity 2884 | Director · Non-Executive Chairman | April 03, 2011 | April 05, 2011 |
| FIVE BELOW, INCFIVE · Entity 3393 | Director | May 04, 2026 | May 06, 2026 |
| PJT Partners Inc.PJT · Entity 3655 | Director | September 16, 2026 | September 18, 2026 |
| YUM BRANDS INCYUM · Entity 3067 | Director | February 10, 2017 | February 13, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BANK OF AMERICA CORP /DE/
Report date April 29, 2009 · Filed May 01, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Unit PlanSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 27,616.64 |
Reported balance
After 2009-03-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2009-03-27 · Grant · Acquired 37.58 · Balance 27,616.64 F1: Reinvested Director Deferred Compensation and Stock Unit Plan dividend Equivalents. Director Deferred Compensation and Stock Unit Plan units may be settled in stock upon death or termination of service as a director. F2: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 31,130.07 |
Reported balance
After 2009-03-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2009-03-27 · Grant · Acquired 42.36 · Balance 31,130.07 F3: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F2: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F4: Phantom stock units may be settled in cash upon death or termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 49,563.25 |
Reported balance
After 2009-04-29 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2009-04-29 · Grant · Acquired 18,433.18 · Balance 49,563.25 F5: Stock units represent payment of the restricted stock portion of the annual Directors' compensation under the Bank of America Corporation Directors' Stock Plan in transactions exempt under Rule 16b-3. F4: Phantom stock units may be settled in cash upon death or termination of service as a director. |
| Common StockSEC Table I · non-derivative | Direct | 57,260 |
Reported balance
Holding disclosure · report date 2009-04-29 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 57,260 |
| Common StockSEC Table I · non-derivative | Indirectby Ryan Family Foundation | 1,175 |
Reported balance
Holding disclosure · report date 2009-04-29 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,175 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse Trust | 804 |
Reported balance
Holding disclosure · report date 2009-04-29 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 804 |
Filing footnotes · ownership attribution and instrument terms
F1: Reinvested Director Deferred Compensation and Stock Unit Plan dividend Equivalents. Director Deferred Compensation and Stock Unit Plan units may be settled in stock upon death or termination of service as a director.
F2: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director.
F3: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director.
F4: Phantom stock units may be settled in cash upon death or termination of service as a director.
F5: Stock units represent payment of the restricted stock portion of the annual Directors' compensation under the Bank of America Corporation Directors' Stock Plan in transactions exempt under Rule 16b-3.
CVS HEALTH Corp
Report date April 03, 2011 · Filed April 05, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust As Beneficiary | 505,743 |
Reported balance
After 2011-01-07 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2011-01-07 · Gift · Disposed 11,150 · Balance 505,743 |
| Common StockSEC Table I · non-derivative | Direct | 1,156,701.9341 |
Reported balance
After 2011-04-03 transaction · row 2
1 source rowRow 2 · 2011-04-03 · Tax withholding · Disposed 27,468 · Balance 1,156,701.9341 F1: Surrender of shares in payment of withholding taxes due. |
| Common StockSEC Table I · non-derivative | IndirectBy Foundation | 67,040 |
Reported balance
Holding disclosure · report date 2011-04-03 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 67,040 |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 481,337.4102 |
Reported balance
Holding disclosure · report date 2011-04-03 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 481,337.4102 |
| ESOP Common StockSEC Table I · non-derivative | IndirectBy ESOP | 8,322.4199 |
Reported balance
Holding disclosure · report date 2011-04-03 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 8,322.4199 |
| Stock UnitSEC Table I · non-derivative | Direct | 1,086,391.5831 |
Reported balance
Holding disclosure · report date 2011-04-03 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 1,086,391.5831 |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of withholding taxes due.
FIVE BELOW, INC
Report date May 04, 2026 · Filed May 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 119,030 |
Reported balance
After 2026-05-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-04 · Grant · Acquired 96 · Balance 119,030 F1: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer payment of $22,500.00, less applicable tax withholdings. F2: Includes shares held by the reporting person's revocable trust. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer payment of $22,500.00, less applicable tax withholdings.
F2: Includes shares held by the reporting person's revocable trust.
PJT Partners Inc.
Report date September 16, 2026 · Filed September 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 11,940 |
Reported balance
After 2026-09-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-16 · Grant · Acquired 19 · Balance 11,940 F1: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock.
F2: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units.
YUM BRANDS INC
Report date February 10, 2017 · Filed February 13, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,749 |
Reported balance
After 2017-02-10 transaction · row 1
1 source rowRow 1 · 2017-02-10 · Grant · Acquired 3,749 · Balance 3,749 |
| Common StockSEC Table I · non-derivative | IndirectRyan Trust | 38,706 |
Reported balance
Holding disclosure · report date 2017-02-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 38,706 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2009 Filed Aug 11, 2009 19:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 400,000 | $0.00 Strike: $19.28 | $0.00 |
DisclosureSEC source: 0001127602-09-017171 · form4.xml · derivative · entry 8 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400,000 shares Expires 2010-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2009 Filed Aug 11, 2009 19:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 400,000 | $34.41 | $13,763,120.00 |
DisclosureSEC source: 0001127602-09-017171 · form4.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 752,080.8778 F1 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $34.23 and $34.47 per share. Read SEC document |
| August 07, 2009 Filed Aug 11, 2009 19:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 400,000 | $19.28 | $7,712,520.00 |
DisclosureSEC source: 0001127602-09-017171 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,152,080.8778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2009 Filed May 1, 2009 17:17 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantPhantom Stock · Derivative | 18,433.18 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-011145 · doc4.xml · derivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,563.25 Underlying: Common Stock · 18,433.18 shares Expires not disclosed F5 · shares: Stock units represent payment of the restricted stock portion of the annual Directors' compensation under the Bank of America Corporation Directors' Stock Plan in transactions exempt under Rule 16b-3. F4 · derivative.exercise_date: Phantom stock units may be settled in cash upon death or termination of service as a director. F4 · derivative.expiration_date: Phantom stock units may be settled in cash upon death or termination of service as a director. Read SEC document |
| April 03, 2009 Filed Apr 7, 2009 20:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 28,933 | $28.45 | $823,143.85 |
DisclosureSEC source: 0001127602-09-008979 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 752,080.8778 F1 · shares: Surrender of shares in payment of withholding taxes due in connection with a previously reported transaction. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 20:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 660,205 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-09-008752 · form4.xml · derivative · entry 7 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 660,205 Underlying: Common Stock · 660,205 shares Expires 2016-04-01 F2 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 20:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 164,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-008752 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,155,592 F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 12/31/2011 and 50% on 12/31/2012. Read SEC document |
| March 27, 2009 Filed May 1, 2009 17:17 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantPhantom Stock · Derivative | 42.36 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-011145 · doc4.xml · derivative · entry 5 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,130.07 Underlying: Common Stock · 42.36 shares Expires not disclosed F3 · shares: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F2 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F4 · derivative.expiration_date: Phantom stock units may be settled in cash upon death or termination of service as a director. Read SEC document |
| March 27, 2009 Filed May 1, 2009 17:17 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantDirector Stock Unit Plan · Derivative | 37.58 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-011145 · doc4.xml · derivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,616.64 Underlying: Common Stock · 37.58 shares Expires not disclosed F1 · shares: Reinvested Director Deferred Compensation and Stock Unit Plan dividend Equivalents. Director Deferred Compensation and Stock Unit Plan units may be settled in stock upon death or termination of service as a director. F2 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F2 · derivative.expiration_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. Read SEC document |
| March 10, 2009 Filed Mar 12, 2009 13:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 1,700 | $0.00 Strike: $25.00 | $0.00 |
DisclosureSEC source: 0001127602-09-006780 · form4.xml · derivative · entry 9 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,300 Underlying: Common Stock · 1,700 shares Expires 2009-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2009 Filed Mar 12, 2009 13:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 1,700 | $25.05 | $42,585.00 |
DisclosureSEC source: 0001127602-09-006780 · form4.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 714,425.8778 Read SEC document |
| March 10, 2009 Filed Mar 12, 2009 13:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 1,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-006780 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716,125.8778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2009 Filed Feb 20, 2009 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 82,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-004358 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,972 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan. Read SEC document |
| February 06, 2009 Filed Feb 6, 2009 19:56 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | PurchaseCommon Stock | 25,000 | $5.62 | $140,500.00 |
DisclosureSEC source: 0001225208-09-003139 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,260 Read SEC document |
| January 21, 2009 Filed Jan 22, 2009 20:58 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | PurchaseCommon Stock | 25,000 | $5.50 | $137,500.00 |
DisclosureSEC source: 0001225208-09-001784 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,260 Read SEC document |
| December 26, 2008 Filed Jan 22, 2009 20:58 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantPhantom Stock · Derivative | 727.2 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-001784 · doc4.xml · derivative · entry 7 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,087.71 Underlying: Common Stock · 727.2 shares Expires not disclosed F2 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F3 · derivative.expiration_date: Phantom stock units may be settled in cash upon death or termination of service as a director. Read SEC document |
| December 26, 2008 Filed Jan 22, 2009 20:58 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantDirector Stock Unit Plan · Derivative | 645.12 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-001784 · doc4.xml · derivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,579.06 Underlying: Common Stock · 645.12 shares Expires not disclosed F1 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F1 · derivative.expiration_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. Read SEC document |
| September 26, 2008 Filed Jan 22, 2009 20:58 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantPhantom Stock · Derivative | 520.37 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-001784 · doc4.xml · derivative · entry 5 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,360.51 Underlying: Common Stock · 520.37 shares Expires not disclosed F2 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F3 · derivative.expiration_date: Phantom stock units may be settled in cash upon death or termination of service as a director. Read SEC document |
| September 26, 2008 Filed Jan 22, 2009 20:58 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantDirector Stock Unit Plan · Derivative | 461.64 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-001784 · doc4.xml · derivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,933.94 Underlying: Common Stock · 461.64 shares Expires not disclosed F1 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F1 · derivative.expiration_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. Read SEC document |
| July 24, 2008 Filed Jul 25, 2008 17:27 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | PurchaseCommon Stock | 1,175 | $32.22 | $37,858.50 |
DisclosureSEC source: 0001225208-08-012447 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Ryan Family Foundation Disclosed balance after: 1,175 Read SEC document |
| June 27, 2008 Filed Jul 25, 2008 17:27 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantPhantom Stock · Derivative | 756.94 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-08-012447 · doc4.xml · derivative · entry 5 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,840.14 Underlying: Common Stock · 756.94 shares Expires not disclosed F2 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F2 · derivative.expiration_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. Read SEC document |
| June 27, 2008 Filed Jul 25, 2008 17:27 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantDirector Stock Unit Plan · Derivative | 671.51 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-08-012447 · doc4.xml · derivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,472.3 Underlying: Common Stock · 671.51 shares Expires not disclosed F1 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F1 · derivative.expiration_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. Read SEC document |
| April 23, 2008 Filed Apr 25, 2008 14:33 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantPhantom Stock · Derivative | 7,053.72 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-08-007045 · doc4.xml · derivative · entry 7 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,083.2 Underlying: Common Stock · 7,053.72 shares Expires not disclosed F5 · shares: Shares represent payment of the annual Directors' compensation under the Bank of America Corporation Directors' Stock Plan in transactions exempt under Rule 16b-3. F4 · derivative.exercise_date: Phantom stock units may be settled in cash upon death or termination of service as a director. F4 · derivative.expiration_date: Phantom stock units may be settled in cash upon death or termination of service as a director. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 634,233 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0000064803-08-000048 · doc.xml · derivative · entry 17 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,233 Underlying: Common Stock · 634,233 shares Expires 2015-04-01 F6 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/1/2009. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 133,593 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000048 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 988,704 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 12/31/10 and 50% on 12/31/2011. Read SEC document |
| March 28, 2008 Filed Apr 25, 2008 14:33 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantPhantom Stock · Derivative | 364.22 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-08-007045 · doc4.xml · derivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,029.48 Underlying: Common Stock · 364.22 shares Expires not disclosed F3 · shares: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F4 · derivative.exercise_date: Phantom stock units may be settled in cash upon death or termination of service as a director. F4 · derivative.expiration_date: Phantom stock units may be settled in cash upon death or termination of service as a director. Read SEC document |
| March 28, 2008 Filed Apr 25, 2008 14:33 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantDirector Stock Unit Plan · Derivative | 426.56 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-08-007045 · doc4.xml · derivative · entry 5 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,800.79 Underlying: Common Stock · 426.56 shares Expires not disclosed F1 · shares: Reinvested Director Deferred Compensation and Stock Unit Plan dividend Equivalents. Director Deferred Compensation and Stock Unit Plan units may be settled in stock upon death or termination of service as a director. F2 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F2 · derivative.expiration_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. Read SEC document |
| February 19, 2008 Filed Feb 21, 2008 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 1,200,000 | $0.00 Strike: $18.66 | $0.00 |
DisclosureSEC source: 0000064803-08-000028 · doc.xml · derivative · entry 18 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,200,000 shares Expires 2008-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 3/12/2001. Read SEC document |
| February 19, 2008 Filed Feb 21, 2008 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 1,200,000 | $40.01 | $48,011,280.00 |
DisclosureSEC source: 0000064803-08-000028 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631,549 F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $39.7050 and 40.3450 per share. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| February 19, 2008 Filed Feb 21, 2008 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 1,200,000 | $18.66 | $22,387,560.00 |
DisclosureSEC source: 0000064803-08-000028 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,831,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| February 12, 2008 Filed Feb 14, 2008 21:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 69,573 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000025 · doc.xml · nonDerivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463,012.1101 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| January 02, 2008 Filed Jan 4, 2008 21:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 155,093 | $39.35 | $6,102,909.55 |
DisclosureSEC source: 0000064803-08-000001 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 630,754 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 28, 2007 Filed Apr 25, 2008 14:33 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantPhantom Stock · Derivative | 332.2 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-08-007045 · doc4.xml · derivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,665.26 Underlying: Common Stock · 332.2 shares Expires not disclosed F3 · shares: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F4 · derivative.exercise_date: Phantom stock units may be settled in cash upon death or termination of service as a director. F4 · derivative.expiration_date: Phantom stock units may be settled in cash upon death or termination of service as a director. Read SEC document |
| December 28, 2007 Filed Apr 25, 2008 14:33 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantDirector Stock Unit Plan · Derivative | 389.07 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-08-007045 · doc4.xml · derivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,374.23 Underlying: Common Stock · 389.07 shares Expires not disclosed F1 · shares: Reinvested Director Deferred Compensation and Stock Unit Plan dividend Equivalents. Director Deferred Compensation and Stock Unit Plan units may be settled in stock upon death or termination of service as a director. F2 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F2 · derivative.expiration_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. Read SEC document |
| November 08, 2007 Filed Nov 15, 2007 21:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 565 | $42.16 | $23,820.40 |
DisclosureSEC source: 0000064803-07-000176 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,528 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| November 06, 2007 Filed Nov 8, 2007 21:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 24,350 | $41.82 | $1,018,317.00 |
DisclosureSEC source: 0000064803-07-000174 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,093 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| November 06, 2007 Filed Feb 4, 2008 21:33 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 12,200 | $41.35 | $504,470.00 |
DisclosureSEC source: 0000064803-08-000013 · doc.xml · nonDerivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By Foundation Disclosed balance after: 37,000 Read SEC document |
| November 06, 2007 Filed Feb 4, 2008 21:33 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 24,350 | $41.82 | $1,018,317.00 |
DisclosureSEC source: 0000064803-08-000013 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,093 F2 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| November 06, 2007 Filed Nov 7, 2007 18:49 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | PurchaseCommon Stock | 3,000 | $45.13 | $135,390.00 |
DisclosureSEC source: 0001225208-07-009716 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,260 Read SEC document |
| November 05, 2007 Filed Nov 8, 2007 21:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 17,030 | $41.35 | $704,190.50 |
DisclosureSEC source: 0000064803-07-000174 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,443 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| November 05, 2007 Filed Feb 4, 2008 21:33 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 17,030 | $41.35 | $704,190.50 |
DisclosureSEC source: 0000064803-08-000013 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,443 F1 · shares: Of the shares gifted by the reporting person on November 5, 2007, 12,200 shares were gifted to a family foundation. The reporting person disclaims beneficial ownership of these shares. F2 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| September 28, 2007 Filed Nov 7, 2007 18:49 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantPhantom Stock · Derivative | 268.19 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-07-009716 · doc4.xml · derivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,333.06 Underlying: Common Stock · 268.19 shares Expires not disclosed F3 · price: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F3 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F3 · derivative.expiration_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. Read SEC document |
| September 28, 2007 Filed Nov 7, 2007 18:49 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantDirector Stock Unit Plan · Derivative | 314.09 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-07-009716 · doc4.xml · derivative · entry 5 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,985.16 Underlying: Common Stock · 314.09 shares Expires not disclosed F2 · price: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F2 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F2 · derivative.expiration_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. Read SEC document |
| August 15, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 101,261 | $0.00 Strike: $18.35 | $0.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · derivative · entry 38 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 101,261 shares Expires 2008-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 02/27/01. Read SEC document |
| August 15, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 100 | $37.59 | $3,759.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 20 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,473 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 15, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 900 | $37.58 | $33,822.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 19 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,573 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 15, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 15,100 | $37.57 | $567,307.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 18 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453,473 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 15, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 300 | $37.56 | $11,268.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 17 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,573 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 15, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 2,900 | $37.54 | $108,866.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 16 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,873 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 15, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 2,500 | $37.53 | $93,825.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 15 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 471,773 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.